Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa

International Journal of Antimicrobial Agents

Volumn 34, Issue 4, 2009, Pages 343-346

  Hirakata, Yoichi ^a   Kondo, Akira ^b   Hoshino, Kazuki ^c   Yano, Hisakazu ^a   Arai, Kazuaki ^a   Hirotani, Ayako ^a   Kunishima, Hiroyuki ^a   Yamamoto, Natsuo ^a   Hatta, Masumitsu ^a   Kitagawa, Miho ^a   Kohno, Shigeru ^b   Kaku, Mitsuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

Efflux pump inhibitors; Invasiveness; MDCK cell; New anti infectious agent; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT; D 13 9001; EFFLUX PUMP INHIBITOR; PHENYLALANYLARGININE 2 NAPHTHYLAMIDE; PHENYLALANYLARGININE BETA NAPHTHYLAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CELL LINE; CULTURE MEDIA; DIPEPTIDES; DRUG RESISTANCE, BACTERIAL; KIDNEY; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PIPERIDINES; PSEUDOMONAS AERUGINOSA; QUATERNARY AMMONIUM COMPOUNDS;

EID: 67651218771     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.06.007     Document Type: Article

References (11)

1. Li X.Z., Nikaido H., and Poole K. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39 (1995) 1948-1953
2. Poole K., and Srikumar R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem 1 (2001) 59-71
3. Li X.Z., Zhang L., Srikumar R., and Poole K. β-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob Agents Chemother 42 (1998) 399-403
4. Li X.Z., Poole K., and Nikaido H. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother 47 (2003) 27-33
5. Li X.Z., Zhang L., and Poole K. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J Bacteriol 180 (1998) 2987-2991
6. Schweizer H.P. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob Agents Chemother 42 (1998) 394-398
7. Hirakata Y., Finlay B.B., Simpson D.A., Kohno S., Kamihira S., and Speert D.P. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J Infect Dis 181 (2000) 765-769
8. Hirakata Y., Srikumar R., Poole K., Gotoh N., Suematsu T., Kohno S., et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med 196 (2002) 109-118
9. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45 (2001) 105-116
10. Yoshida K., Nakayama K., Ohtsuka M., Kuru N., Yokomizo Y., Sakamoto A., et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7. Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate. Bioorg Med Chem 15 (2007) 7087-7097
11. Masuda N., and Ohya S. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 36 (1992) 1847-1851